New COP Allergy Vaccine for Patients Allergic to House Dust Mites
Anergis develops a COP allergy vaccine for patients with house dust mite allergy.
Allergy to house dust mites is the most frequent and potentially harmful cause of allergy. It may be a causing factor in 50 to 80% of asthmatics, as well as eczema, rhinitis and rhino-conjunctivitis.
Potential patients are spread worldwide, with very high number of sufferers (60 million in Europe, 30 million in US, 20 million in Japan and 60 million in China).
The COP allergy vaccine against house dust mites allergy is currently in pre-clinical development.